Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kiniksa Pharmaceuticals International Plc (KNSA)

Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)
  12-2023 12-2022 12-2021 12-2020 12-2019
Assets
Current Assets
Cash & Cash Equivalents 107,954 122,715 122,470 114,248 46,928
Marketable Securities 98,417 67,893 59,731 209,444 186,452
Receivables 21,266 12,660 3,985 N/A N/A
Inventories 31,122 21,599 3,675 N/A N/A
Other current assets 0 7,656 0 0 0
TOTAL $276,297 $243,060 $196,446 $333,249 $241,627
Non-Current Assets
PPE Net 734 1,658 2,834 4,051 6,398
Intangibles 17,250 18,250 19,250 0 0
Other Non-Current Assets 232,041 196,704 14,270 12,164 6,509
TOTAL $250,025 $216,612 $36,354 $16,215 $12,907
Total Assets $526,322 $459,672 $232,800 $349,464 $254,534
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 8,246 7,899 1,868 503 5,693
Accrued Expenses 44,667 30,112 38,031 29,199 20,415
Other current liabilities 8,193 5,754 1,544 37 25
TOTAL $63,666 $47,066 $44,824 $31,846 $27,830
Non-Current Liabilities
Deferred Revenues 307 N/A N/A N/A N/A
aiOther Non-Current Liabilities 11,863 4,457 2,939 5,683 1,281
TOTAL $23,817 $16,457 $2,939 $5,683 $1,281
Total Liabilities $87,483 $63,523 $47,763 $37,529 $29,111
Shareholders' Equity
Shares Outstanding, K 70,615 69,753 69,104 68,232 55,547
Common Shares 20 19 18 18 15
Retained earnings -477,950 -492,034 -675,397 -517,473 -356,092
Other shareholders' equity 6 44 -66 -34 33
TOTAL $438,839 $396,149 $185,037 $311,935 $225,423
Total Liabilities And Equity $526,322 $459,672 $232,800 $349,464 $254,534
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar